Brind.

Merck KGaA agreed to acquire Bio-Techne, while an analyst boosted the price target for Avantor stock.

1 report, 1 independent Updated Jun 25

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Merck KGaA Bio-Techne Avantor

Keep exploring

The entities involved

Merck KGaA
German multinational science and technology company
- MSD, which operates as Merck & Co. in the US and Canada, has appointed Vidhya as Associate Vice President.Mon 12:02
- Merck KGaA filed required 13F reports with the Securities and Exchange Commission regarding institutional holdings on June 15, 2026.Mon 02:05
Bio-Techne
company
- Bio-Techne has entered a strategic partnership with Spear Bio to distribute its immunoassays, advancing therapeutic development.Sun 13:32
- Trump pledged to unleash American oil and gas, involving MBX Biosciences, Inc.Sun 05:01
Avantor
U.S. chemical company
- Trump's oil and gas pledges benefit US stocks, specifically impacting Pfizer.Sun 04:48

Related events

Merck KGaA announced a definitive agreement to acquire Bio-Techne.Jun 25
Merck KGaA operates as a science and technology company in Germany.Jun 25

Coverage

Newest first; wire copies grouped

Jun 25financialcontent.com